Compound ID | 3516
VesiX CPC
Class: Membrane-active agent
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad-spectrum; active against recurrent urinary tract infection (rUTI) caused by uropathogenic Escherichia coli (UPEC), Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterococcus faecalis; membrane-active agent |
| Description: | Synthetic compound; intravesical therapy containing cetylpyridinium chloride (CPC) as active antimicrobial ingredient (an established active ingredient in oral hygiene products); designed for instillation treatment for women with rUTI |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Limited clinical trial |
| Development status: | Experimental |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.